Published in Support Care Cancer on May 31, 2014
Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy. PLoS One (2015) 0.86
Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage. Neural Regen Res (2017) 0.75
Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients. Support Care Cancer (2017) 0.75
The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature. Lasers Med Sci (2016) 0.75
Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain (2007) 6.98
Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA (1998) 5.91
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc (2010) 3.92
Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med (2003) 3.82
Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology (2002) 3.21
Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain (2006) 2.71
Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology (2003) 2.62
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol (2008) 2.60
Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain (2005) 2.55
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology (2008) 2.48
Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care (2008) 2.47
Treatment of neuropathic pain: an overview of recent guidelines. Am J Med (2009) 2.43
Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain (2004) 2.38
Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain (2002) 2.32
Managing chronic pain: results from an open-label study using MC5-A Calmare® device. Support Care Cancer (2011) 2.29
Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care (2006) 2.25
Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr Biol (2006) 2.18
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology (2006) 2.05
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med (2005) 1.99
Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain (2005) 1.97
Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer (2007) 1.94
Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain (2003) 1.85
Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia (1986) 1.82
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol (2013) 1.81
Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther (2004) 1.67
Antidepressants for neuropathic pain. Cochrane Database Syst Rev (2007) 1.66
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med (2004) 1.65
Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Eur J Pain (2007) 1.49
Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain (2004) 1.47
200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial. Pain (1999) 1.43
A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet (2010) 1.41
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer (2010) 1.41
Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer (2008) 1.40
Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage (2010) 1.39
Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care (2005) 1.35
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol (2011) 1.35
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manage (2007) 1.34
Scrambler therapy. Minerva Anestesiol (2005) 1.32
Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies. Curr Med Chem (2008) 1.32
Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care (1995) 1.31
Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial. J Pain Symptom Manage (2011) 1.29
Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP (2003) 1.29
Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev (2013) 1.27
Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. Eur J Cancer (2005) 1.25
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain (2002) 1.24
Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility. Oncologist (2011) 1.22
Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology (2003) 1.20
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat (2010) 1.19
Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain (2002) 1.18
Acupuncture treatment for chemotherapy-induced peripheral neuropathy--a case series. Acupunct Med (2006) 1.16
Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract (1998) 1.16
Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupunct Med (2011) 1.14
A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology (2000) 1.14
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA. Support Care Cancer (2011) 1.12
Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol (2008) 1.11
Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology (2003) 1.08
Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients. J Pain (2011) 1.06
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann Oncol (2013) 1.05
Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain. J Neurochem (2010) 1.05
Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Cancer (2011) 1.05
Exercise for people with peripheral neuropathy. Cochrane Database Syst Rev (2004) 1.03
Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology (2001) 1.03
Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography. Acupunct Med (2011) 1.01
The effect of menthol on cold allodynia in patients with neuropathic pain. Pain Med (2008) 1.01
Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain (2005) 0.99
A trial of Scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. J Pain Palliat Care Pharmacother (2013) 0.98
Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid. J Clin Oncol (2002) 0.98
Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev (2012) 0.97
Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology (2005) 0.96
Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology (2001) 0.96
A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy. Tumori (2005) 0.95
A novel treatment of postherpetic neuralgia using peppermint oil. Clin J Pain (2002) 0.94
Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy. Anticancer Res (2010) 0.93
Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid. Ann Oncol (2003) 0.93
A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain (2003) 0.92
Fall and balance outcomes after an intervention to promote leg strength, balance, and walking in people with diabetic peripheral neuropathy: "feet first" randomized controlled trial. Phys Ther (2010) 0.91
Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer (2013) 0.91
Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. J Pain Symptom Manage (2007) 0.91
Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies. Expert Opin Investig Drugs (2004) 0.90
Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review. CNS Drugs (2007) 0.90
Effect of transcutaneous electrical nerve stimulation on symptomatic diabetic peripheral neuropathy: a meta-analysis of randomized controlled trials. Diabetes Res Clin Pract (2010) 0.89
Role of acetyl-L-carnitine in the treatment of diabetic peripheral neuropathy. Ann Pharmacother (2008) 0.88
Protection against oxaliplatin acute neurosensory toxicity by venlafaxine. Anticancer Drugs (2003) 0.88
Electrotherapy for the treatment of painful diabetic peripheral neuropathy: a review. J Rehabil Med (2010) 0.88
Fifteen-day acupuncture treatment relieves diabetic peripheral neuropathy. J Acupunct Meridian Stud (2010) 0.87
Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study. Support Care Cancer (2011) 0.87
Acetyl-L-carnitine in neuropathic pain: experimental data. CNS Drugs (2007) 0.87
GABA(B) receptor agonist baclofen has non-specific antinociceptive effect in the model of peripheral neuropathy in the rat. Physiol Res (2004) 0.86
[Clinical randomized controlled study on acupuncture for treatment of peripheral neuropathy induced by chemotherapeutic drugs]. Zhongguo Zhen Jiu (2010) 0.86
Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data. CNS Drugs (2007) 0.85
Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy. Pain (2011) 0.84
From bench to bedside: a case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 activator, menthol. J Clin Oncol (2008) 0.84
Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy. Anticancer Drugs (2005) 0.84
A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors. Support Care Cancer (2014) 0.83
Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery. J Pain Symptom Manage (2010) 0.83
Topical ketamine gel: possible role in treating neuropathic pain. Pain Med (2000) 0.83
Clinical study on the wrist-ankle acupuncture treatment for 30 cases of diabetic peripheral neuritis. J Tradit Chin Med (2006) 0.83
Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma. Support Care Cancer (2012) 0.83
A human protein-protein interaction network: a resource for annotating the proteome. Cell (2005) 18.97
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol (2004) 7.36
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med (2003) 6.99
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol (2009) 4.32
Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol (2010) 4.30
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2005) 4.10
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med (2014) 3.86
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol (2012) 3.26
Cancer-related fatigue: the scale of the problem. Oncologist (2007) 3.03
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol (2009) 2.88
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med (2008) 2.74
Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9. J Clin Oncol (2010) 2.57
Pathophysiology and treatment of hot flashes. Mayo Clin Proc (2002) 2.56
An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol (2004) 2.45
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial. Support Care Cancer (2010) 2.43
Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol (2013) 2.43
Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol (2002) 2.33
Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst (2007) 2.31
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol (2010) 2.28
Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma. Ann Surg Oncol (2004) 2.27
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol (2002) 2.09
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Neurology (2013) 1.98
Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer (2007) 1.94
Defining venous involvement in borderline resectable pancreatic cancer. Ann Surg Oncol (2010) 1.93
Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132. Ann Surg Oncol (2011) 1.86
Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol (2011) 1.79
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Support Care Cancer (2011) 1.78
Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. J Clin Oncol (2008) 1.77
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer (2014) 1.76
Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer. J Clin Oncol (2006) 1.76
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer (2006) 1.72
An item response theory-based pain item bank can enhance measurement precision. J Pain Symptom Manage (2005) 1.68
Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol (2004) 1.66
Validation of the S-LANSS in the community setting. Pain (2007) 1.65
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia. J Clin Oncol (2010) 1.61
The prevalence of weight concerns in a smoking abstinence clinical trial. Addict Behav (2005) 1.60
The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg (2004) 1.57
A pilot study of long-acting octreotide for symptomatic malignant ascites. Oncology (2012) 1.56
Patients' experiences with navigation for cancer care. Patient Educ Couns (2009) 1.55
Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model. J Clin Oncol (2011) 1.55
Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest (2004) 1.55
Physical activity monitoring: a responsive and meaningful patient-centered outcome for surgery, chemotherapy, or radiotherapy? J Pain Symptom Manage (2012) 1.54
Yoga improves quality of life and benefit finding in women undergoing radiotherapy for breast cancer. J Soc Integr Oncol (2010) 1.53
International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature. J Clin Oncol (2007) 1.50
Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst (2013) 1.47
Better off dead: suicidal thoughts in cancer patients. J Clin Oncol (2008) 1.46
Hematoma risk after needle electromyography. Muscle Nerve (2012) 1.46
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma. Blood (2011) 1.44
Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Support Care Cancer (2002) 1.44
International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer (2007) 1.44
Family caregiver skills in medication management for hospice patients: a qualitative study to define a construct. J Gerontol B Psychol Sci Soc Sci (2009) 1.43
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer (2010) 1.41
Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer (2008) 1.40
Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252. Clin Breast Cancer (2005) 1.40
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol (2004) 1.40
Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist (2007) 1.36
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. J Clin Oncol (2003) 1.36
High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology (2008) 1.34
Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Qual Life Res (2013) 1.33
Proteomic analyses of pancreatic cyst fluids. Pancreas (2009) 1.29
Patient navigation for breast and colorectal cancer treatment: a randomized trial. Cancer Epidemiol Biomarkers Prev (2012) 1.29
Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer (2009) 1.28
Gastrointestinal stromal tumors. Hematol Oncol Clin North Am (2005) 1.27
Epoetin alfa and darbepoetin alfa go head to head. J Clin Oncol (2006) 1.27
Study protocol: a randomized controlled trial of patient navigation-activation to reduce cancer health disparities. BMC Cancer (2010) 1.26
Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther (2008) 1.26
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain (2002) 1.24
Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol (2012) 1.24
Communication about sexuality and intimacy in couples affected by lung cancer and their clinical-care providers. Psychooncology (2011) 1.21
Coprescription of tamoxifen and medications that inhibit CYP2D6. J Clin Oncol (2010) 1.21
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial. Mayo Clin Proc (2006) 1.20
Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. PLoS One (2012) 1.20
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Mayo Clin Proc (2007) 1.19
Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice. Mol Pain (2010) 1.19
Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol (2011) 1.17
Social and cultural factors are related to perceived colorectal cancer screening benefits and intentions in African Americans. J Behav Med (2009) 1.15
Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia. Ann Pharmacother (2008) 1.15
Conservative management of L-asparaginase-induced hypertriglyceridemia in an adult patient: a case report and review of the literature. Onkologie (2012) 1.14
Final recommendations for a voluntary national accreditation program for state and local health departments: steering committee report. J Public Health Manag Pract (2007) 1.14
Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol (2006) 1.14
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2011) 1.13
Behavioral interventions in treating anticipatory nausea and vomiting. J Natl Compr Canc Netw (2007) 1.13
Therapy for chemotherapy-induced peripheral neuropathy. JAMA (2013) 1.13
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA. Support Care Cancer (2011) 1.12
Two-dimensional ultrasound imaging of the diaphragm: quantitative values in normal subjects. Muscle Nerve (2013) 1.11
Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions. Int J Womens Health (2010) 1.11
Caring for Somali women: implications for clinician-patient communication. Patient Educ Couns (2007) 1.10
Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer (2013) 1.10
Rapid improvement in pain management: the Veterans Health Administration and the institute for healthcare improvement collaborative. Clin J Pain (2003) 1.10
Patient-reported outcome measures suitable to assessment of patient navigation. Cancer (2011) 1.09
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC. Breast Cancer Res Treat (2009) 1.09
Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer (2008) 1.08
Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol (2010) 1.07
Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys (2010) 1.07
Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapy. Support Care Cancer (2014) 1.07
Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist (2003) 1.07
Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol (2002) 1.06